Chagas Cardiomyopathy Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, H1, 2012' provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Cardiomyopathy . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Keywords
Chagas Cardiomyopathy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Chagas Cardiomyopathy , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Summary
GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, H1, 2012' provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Cardiomyopathy . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Chagas Cardiomyopathy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Chagas Cardiomyopathy , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Introduction
Chagas Cardiomyopathy
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Chagas Cardiomyopathy
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bayer AG
Clinical Trial Overview of Bayer AG
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University Medical Center Goettingen
Clinical Trial Overview of University Medical Center Goettingen
The Institute of Cardiology (IC)
Clinical Trial Overview of The Institute of Cardiology (IC)
Federal University of Minas Gerais
Clinical Trial Overview of Federal University of Minas Gerais
Tohoku University
Clinical Trial Overview of Tohoku University
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Texas Southwestern Medical Center at Dallas
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas
The Cleveland Clinic
Clinical Trial Overview of The Cleveland Clinic
Virginia Commonwealth University
Clinical Trial Overview of Virginia Commonwealth University
VU University Medical Center
Clinical Trial Overview of VU University Medical Center
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Medical University of Silesia
Clinical Trial Overview of Medical University of Silesia
The Hospital for Sick Children
Clinical Trial Overview of The Hospital for Sick Children
University of Michigan
Clinical Trial Overview of University of Michigan
Charles University
Clinical Trial Overview of Charles University
University of Calgary
Clinical Trial Overview of University of Calgary
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, BRIC Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, G7 Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, E7 Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Goettingen, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Institute of Cardiology (IC), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Minas Gerais, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
LIST OF FIGURES
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, G7 Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, E7 Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Chagas Cardiomyopathy
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Chagas Cardiomyopathy
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bayer AG
Clinical Trial Overview of Bayer AG
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University Medical Center Goettingen
Clinical Trial Overview of University Medical Center Goettingen
The Institute of Cardiology (IC)
Clinical Trial Overview of The Institute of Cardiology (IC)
Federal University of Minas Gerais
Clinical Trial Overview of Federal University of Minas Gerais
Tohoku University
Clinical Trial Overview of Tohoku University
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Texas Southwestern Medical Center at Dallas
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas
The Cleveland Clinic
Clinical Trial Overview of The Cleveland Clinic
Virginia Commonwealth University
Clinical Trial Overview of Virginia Commonwealth University
VU University Medical Center
Clinical Trial Overview of VU University Medical Center
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Medical University of Silesia
Clinical Trial Overview of Medical University of Silesia
The Hospital for Sick Children
Clinical Trial Overview of The Hospital for Sick Children
University of Michigan
Clinical Trial Overview of University of Michigan
Charles University
Clinical Trial Overview of Charles University
University of Calgary
Clinical Trial Overview of University of Calgary
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, BRIC Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, G7 Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, E7 Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Goettingen, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Institute of Cardiology (IC), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Minas Gerais, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
LIST OF FIGURES
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, G7 Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, E7 Countries (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
